You are MORE likely to get Covid again within weeks if you take Paxlovid

People seem more likely to experience a Covid rebound when using Pfizer’s antiviral drug Paxlovid, according to a study.

In recent months, President Joe Biden, Dr. Anthony Fauci and CDC Director Dr. Rochelle Walensky all quickly tested positive again after they stopped taking the drug.

Scientists at the Scripps Research Translational Institute in La Jolla, California, compared 127 infected people taking Paxlovid with 43 others who beat the virus without the drug.

They found that 14 percent of Paxlovid users tested positive for the virus in the weeks after recovery. Meanwhile, just nine percent in the group that didn’t use the antiviral tested positive again.

The study was small and the researchers aren’t sure the results weren’t coincidental, but they want to confirm them in a future study of 800 people.

The exact causes of the rebound are unknown, but doctors suspect it is due to the way the drug works. Instead of killing the virus outright, Paxlovid Stop its replication inside the body.

Experts believe that after being suppressed by Paxlovid, Covid will rebound as the drug disappears from the body, leading to high levels of the virus and strong immune responses that could cause symptoms to reappear.

Notable examples of the Covid rebounds include President Joe Biden, who suffered a rebound after contracting the virus and receiving Paxlovid in June

Two of America’s top health officials, Drs. Fauci, the nation’s leading infectious disease expert, and Dr. Walensky, director of the Centers for Disease Control and Prevention (CDC), were also affected.

One study found that Paxlovid recipients were twice as likely to either experience a symptom rebound or test positive for COVID-19 again than people who did not use the drug

One study found that Paxlovid recipients were twice as likely to either experience a symptom rebound or test positive for COVID-19 again than people who did not use the drug

President Joe Biden (pictured) is a strong supporter of Paxlovid and during his State of the Union address earlier this year announced the test-to-treat program, making the drug free for Americans infected with Covid

President Joe Biden (pictured) is a strong supporter of Paxlovid and during his State of the Union address earlier this year announced the test-to-treat program, making the drug free for Americans infected with Covid

What is Paxlovid?

Paxlovid is an antiviral drug developed and manufactured by New York City-based pharmaceutical giant Pfizer.

It is intended for people who are seriously ill as a result of their infection or who have comorbidities that put them at risk of serious complications caused by the virus.

The FDA approved it for use in the United States in December. In March, President Joe Biden launched the “Test to Treat” program, which offered the drug free to Americans who tested positive for the virus.

It comes in a course of 30 pills. The tablets are to be taken in threes twice a day for five days.

In clinical trials, it showed it could reduce the chance of hospitalization or death from the virus in at-risk patients by 90 percent.

In May, the CDC issued a warning that some people taking the drug would face a return of symptoms in the weeks after recovering from Covid.

The drug was heralded by President Biden as one of the silver bullets to fight the pandemic at his 2022 State of the Union address.

Paxlovid was the focus of its Test to Treat Covid program it launched earlier this year, which it offered to Americans who tested positive for the virus at select pharmacies.

It is prescribed as three pills taken twice a day for five days

The studyavailable in pre-print and awaiting peer review, collected data from 170 patients.

Each of the patients was offered Paxlovid after testing positive for the virus. Among them, 127 accepted the offer, while 43 decided not to use the drug.

Patients also received 12 home COVID-19 tests and were instructed to test themselves every other day.

They reported test results and daily symptoms to the researchers.

In the weeks after completing the course, 18 people in the Paxlovid group, or 14 percent, tested positive for the virus again.

Another 22 or 19 per cent of the study group said their Covid symptoms had returned but did not record a positive test.

In the control group, only four testicles were positive again – nine percent – while three symptoms returned despite negative swabs – or seven percent.

Overall, 33 percent of Paxlovid users and 16 percent of non-users experienced either a recurrence of symptoms or a positive test after recovering from the virus.

dr Michael Charness, chief of staff for the Veterans Affairs Boston Healthcare System, told CNN, “There is evidence that symptomatic rebound is more common in Paxlovid-treated participants than in untreated controls, but larger numbers are needed to draw reliable conclusions.” “

This study is another setback for Paxlovid, which was billed as a pandemic “game changer” when it launched in late 2021.

Clinical studies have shown that it reduces the likelihood of hospitalizations or deaths caused by the virus by 90 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *